Hexoskin is set to launch its 7th Astroskin payload in collaboration with the Canadian Space Agency this week aboard a SpaceX rocket.
CRS-21 is the first launch of phase 2 of SpaceX's Commercial Resupply Service (CRS) contract. The mission will use the Cargo version of the Dragon 2 spacecraft on top of a Falcon 9 rocket launching from Kennedy Space Center in Florida.
This mission is planned to use Booster B1058.4 (4th flight for booster B1058). This recent booster is the one that carried NASA astronauts Doug Hurley and Bob Behnken to the International Space Station on May 30th, 2020, the first US rocket carrying astronauts since Space Shuttle Atlantis in July 2011.
Microgravity affects fluid movements in the body and heat transmission (in the absence of convection movement in microgravity). This triggers physiological phenomena impossible to monitor on the ground and tests our models of human physiology. The Astroskin Bio-Monitor system gives scientists a tool to observe these phenomena in space. It also prepares us to maintain crew health during long space missions beyond low earth orbit (LEO), to the Moon and Mars.
Astronauts from 3 different space agencies (NASA, CSA, ESA) have used the Astroskin system aboard the International Space Station since January 2019.
Here's a list of space launches that carried Astroskin payloads:
Hexoskin's CEO Pierre-Alexandre Fournier was invited to speak at a seminar co-hosted by Stanford eWEAR and Stanford Medicine's Precision Health and Integrated Diagnostics Center (PHIND) held online on December 1st. The seminar covered the capabilities of wearable technologies and Hexoskin to support the early detection of diseases such as the COVID-19 onset.
With over 100 Scientific Publications and validations, Hexoskin has the only clinically validated biometric garment which provides continuous monitoring of numerous and unique physiological parameters. It is an enabling technology for telehealth use cases, such as remote patient monitoring, at-home cardiovascular and pulmonary rehabilitation, and post-acute care.
Along with its smart clothing, Hexoskin offers a unique set of high-resolution biometric data that can continuously monitor activity, sleep, cardiac and respiratory data. Projects in fields such as cardiology, respiratory, behavioral and physiological psychology, biofeedback research, sleep research, and health will be presented during the seminar.
The Hexoskin Connected Health Platform provides researchers with accessible solutions such as the Hexoskin Dashboards, Open API, and Apps to manage, visualize, annotate, analyze, and export raw & processed health data. Data extraction tools allow access to the raw data with time series for machine learning and artificial intelligence projects, making Hexoskin and excellent solution to collect high-resolution data quickly to deliver projects and results. Watch it online today!
With another wave of COVID-19 patients hitting North America and Europe, conducting clinical research is challenging. Patient recruitment and access to facilities are limited in many research institutions to limit risks to participants and researchers.
Thankfully, we can now conduct a lot of research remotely while ensuring the collection of high-quality data and preserving the integrity of clinical assessments.
Sponsors and CROs are looking for solutions to help them manage halted clinical trials or start new trials while ensuring that key considerations are met. Connected devices like the Hexoskin shirts are available to support the collection of objective sensor data for virtual and home-based studies. Smartphones can also provide instructions, interactive sessions, and facilitate clinical outcome assessments with limited supervision. Recruitment can be done online with the equipment required for the study shipped overnight to participants.
The Hexoskin Connected Health Platform is an end-to-end open platform that supports virtual clinical trials which can be completed partially or entirely remotely. The Hexoskin team can help you and your team design protocols and patient-centered studies. Home-based trials give patients better options to join clinical trials while limiting the burden associated with transportation and site visits. Online reach helps you recruit a more diverse participant base and overcome recruiting challenges.
Since the launch of Hexoskin in 2013, hundreds of researchers have used the Hexoskin platform successfully for their research using Hexoskin and Astroskin systems. They appreciate the transparency and traceability the platform offers. Hexoskin also provides service-level support and a wide range of study-management tools designed to support remote patient monitoring protocols.
More than ever, patients are counting on the work of the clinical research industry to push the boundaries of medical knowledge.
Let's work together to support trial continuity and patient engagement! Contact us at firstname.lastname@example.org to discuss your objectives and explore how Hexoskin can help you scale your remote studies.
Today Hexoskin has reached an important milestone. The Hexoskin Connected Health Platform has been used in over 100 scientific & peer-reviewed publications thanks to our community of researchers and scientists dedicated to promoting safe and effective remote monitoring technologies!
But who’s counting? Actually... we do! Our Hexoskin Smart Clothing solutions benefit from the most validation and publications in the industry, accounting for more than all the smart clothing competition combined.
The publications and validations studies cover a wide range of fields of study from scientific validations of the Hexoskin Cardiac, Pulmonary, and Activity smart clothing sensors; to various subjects and health applications.
It’s been such a wonderful experience to reach this milestone and we are thankful for the trust placed in our Hexoskin Connected Health Solutions. We can’t wait to continue this journey to improve evidence-based practice for patients and professionals by bringing science to new levels!
Chronic stress induces harmful and insidious repercussions on the general state of health of individuals. The effects of stressors are not always immediate and can persist over time, particularly if the stressor is consistently present. As the tolerance level of individuals varies according to type, intensity, and length of the stressor, monitoring the impact of chronic stress on human physiology must be performed in a similar fashion. Ambulatory devices fulfill such requirements, as they are geared towards collecting real-world evidence to identify biometric variations and support the development and implementation of preventative approaches. However, few current portable technologies allow for multiple physiological data points to be measured simultaneously, continuously, all while being contextualized.
To learn more about Hexoskin’s digital health solutions for Stress monitoring, we invite you to download our latest White Paper titled:
Predicting and Preventing Operational Stress Injuries Using the Hexoskin Connected Health Platform.
In this White Paper, we explore:
We also invite you to request our Summary of Scientific Publications on Stress.
During these challenging times, the health of healthcare workers is now in the spotlight. Healthcare staff are experiencing stressful events which could lead to operational stress injury (OSI). If not assessed and addressed early, OSI can lead to post-traumatic stress injuries.
Our guest speaker, Dr. Nicholas Slamon (former director of the Nemours Alfred I. duPont Hospital for Children) has kindly shared his experience and work with Hexoskin during our Webinar on Stress Monitoring with Hexoskin. Dr. Slamon and colleagues assessed the feasibility of using Hexoskin to monitor physiological data of pediatric critical care physicians during real-life contexts and stressful medical situations. Ultimately, Dr. Slamon aimed to characterize critical care stressors that might over time impact the physicians’ performance and general health.
Stress Monitoring with Hexoskin, Webinar, 2017. Request the Webinar's recording
Do you have a project in mind? Looking for advice on how wearables & smart garments can monitor patients continuously and remotely to gather real-world evidence for your project?
Contact our experienced team at email@example.com or call 1 888 887 2044.
Hexoskin's CEO Pierre-Alexandre Fournier joined astronaut David Saint-Jacques and other panelists this week to discuss innovation in space medicine at the Virtual MedTech Conference.
After 20 years of continuous human presence on the International Space Station, countries from around the world are getting ready to send humans farther into our solar system, beyond Earth's orbit. Technologies required to support long-duration missions, such as to Mars and back to the moon, will be critical to the next 50 years of space exploration.
The Canadian Space Agency, numerous innovative Canadian medical technology companies and the National Research Council of Canada, are performing key research to develop and incorporate novel medical devices solutions for long-duration human spaceflight.
Cutting-edge microgravity research and space-relevant clinical expertise are critical to ensure an autonomous crew health care system. Canadian scientists, clinicians and specialists have developed and demonstrated new devices for remote clinical care including point of care diagnostics and real-time astronaut monitoring.
Among these innovations, Hexoskin has launched the wearable Astroskin Bio-Monitor system to the International Space Station in 2018 to monitor astronaut's vital signs. The system is used since for medical research in micro-gravity but also for research on Earth by a wide community of clinicians working in universities and research centers around the world.
The video of the MedTech Conference panel has been published and is available on the conference platform for attendees here: https://medtechvirtual2020.pathable.co/meetings/virtual/v98noBALBh3R4Xa5e
For a second year, Hexoskin was invited to present at the Intelligent Health AI Summit.
On Wednesday, September 9th, Hexoskin's Co-founder & CEO Pierre-Alexandre Fournier gave a presentation on chronic disease management and the challenges of data collection when developing AI solutions for healthcare.
Due to the COVID-19 pandemic, Intelligent Health AI Summit 2020 is held online. To view the program and to register please follow this link: https://intelligenthealth.ai/programme/
Hexoskin has a dedicated group of AI & biomedical researchers with years of experience in preparing and analyzing health data, and in the development of machine learning algorithms with health data. Our research team support the collection of vital signs with smart clothing and use external datasets to answer novel research questions.
If you wish to learn more on Hexoskin's Artificial Intelligence capabilities for Cardiovascular & Respiratory Health Research, we invite you to request access to our Webinar, with our Co-founders Pierre-Alexandre Fournier and Jean-François Roy, and our guest speaker Dr. Thomas Beltrame PhD. Department of Physiotherapy - Federal University of São Carlos. Institute of Computing - University of Campinas. Request the Webinar's recording
Thank you to all our Attendees and Guests Speakers who participated in our Live Webinar on Continuous & Remote Respiratory Monitoring with Hexoskin - In the Era of Chronic Illness, Pandemics & Limited Health Resources, on August 25th, 2020! If you were not able to attend live, and wish to watch it, you can now access the Webinar's recording:
Over 250 guests registered for this panel with our guest speakers Dr. Dennis Jensen (McGill University), and Denise Mannée (Radboud University Medical Center). In this session we discussed the benefits and considerations of digital technologies for Healthcare Providers, Researchers and Patients, and provide real-world evidence of Hexoskin's remote respiratory monitoring capabilities.
The introduction of digital technologies has promulgated innovative platforms aimed at reducing the gaps in respiratory disease management and research. How are they used? How can we distinguish effective programs from the hundreds of available digital solutions? This webinar will discuss the benefits and considerations of digital technologies for Healthcare Providers, Researchers and Patients, and provide real-world evidence of Hexoskin's remote respiratory monitoring capabilities.
Join us with our guest speakers on Tuesday, August 25, 2020, at 11:00 AM (EDT), for the upcoming Hexoskin Live Webinar on Continuously & Remote Respiratory Monitoring. If you are unable to attend, you can still register and we will send you the recorded webinar by email afterwards.
Register today to reserve your spot!
We look forward to your presence for this special event!
Over the last few weeks, the global number of confirmed cases of COVID-19 has dramatically increased, leading to critically elevated hospitalization rates and emergency room overcrowding . Shortage of beds and equipment in addition to staff exhaustion are aggravating the already fragile and precarious situation in hospitals [2–4]. This setting has created an unprecedented strain on healthcare systems, thereby compromising the quality of patient care [2,4]. Despite the concerted efforts of scientists and clinicians to find an effective vaccine, this health crisis will likely persist longer than expected . Therefore, all efforts should be directed to confirm and deploy approaches to relieve healthcare systems before they crumble under pressure [3,4,6,7]. One such strategy is the early recognition of clinical deterioration, which limits the spread of the disease and reduces unnecessary hospital demands .
A growing body of evidence supports the clinical relevance of respiratory rate (RR) as a key predictor for adverse health outcomes [8–11]. In patients affected by COVID-19, an increase of RR can be a warning sign for patient deterioration and criteria for ICU transfer . Massaroni et al. suggested that the current situation has ironically generated the perfect conditions for wearables to demonstrate their worth and capabilities to alleviate caregivers’ workload in this time of crisis. According to the authors, digital health respiratory monitoring technologies can provide relevant data to facilitate effective remote triage, diagnosis and symptoms monitoring. This will positively impact care assistance for self-isolated patients . A wide variety of technologies for RR monitoring have been developed, tested and are commercially available [14–16]. However, these portable health technologies are not all comparable in terms of design, validity and usability [14–19].
Hexoskin stands out against other contenders in the respiratory field as a result of its strong presence in research publications, but also in consequence of the clinical validation of its biometric data [14,16]. Hexoskin supports professionals & researchers to improve their standards of care and research by providing cutting edge health sensors, and state-of-the-art health data management & analysis software.
To learn more about Hexoskin’s digital health solutions for RR monitoring, we invite you to download our latest White Paper titled: A comparative Perspective on Wearables Key Features for Advanced Respiratory Monitoring. In this White Paper, we explore: